Skip to content

Nasdaq · CIK 0001325618

IRMD IRADIMED CORP

Insider trading from SEC Form 4. Last filing 17 d ago. Close $87.45 on Oct 9, 2026, +24% from the 52-week low and -16% from the high.

Last 90 days

Net insider value
-$123k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$123k by 1 insider
Insiders on file
7
with a Form 4 at this company

Price and insider trades, last year

IRMDOct 9, 2026 · close 87.45

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at IRADIMED CORP, scored.

ScoreInsiderValueHoldingsPrice contextFiled
25WeakMonty K Allen
director
sell
$123k
1,419 shares
-7%-
23WeakMonty K Allen
director
sell
$76k
1,102 shares
-5%+52% from low-1% from high
43ModerateJohn Glenn
CHIEF FINANCIAL OFFICER
sell
$135k
2,500 shares
-36%-
31WeakAnthony Vuoto
director
sell
$151k
2,690 shares
-16%-

Transactions

The last 39 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 23, 2026Joe E Kiani
director
MOption exercise
Common Stock
+698--69817 d ago
Sep 23, 2026Joe E Kiani
director
MOption exercise
Restricted Stock Unitsderivative
-698$0.00$01,39717 d ago
Sep 3, 2026Monty K Allen
director
SOpen-market sale
Common Stock
-1,014$86.44$88k19,98634 d ago
Sep 3, 2026Monty K Allen
director
SOpen-market sale
Common Stock
-405$86.35$35k19,58134 d ago
Aug 6, 2025Monty K Allen
director
SOpen-market sale
Common Stock
-1,102$69.10$76k19,898Aug 6, 2025
Jun 20, 2025John Glenn
CHIEF FINANCIAL OFFICER
MOption exercise
Common Stock
+5,796--14,563Jun 23, 2025
Jun 20, 2025John Glenn
CHIEF FINANCIAL OFFICER
FTax withholding
Common Stock
-1,412$58.24$82k13,151Jun 23, 2025
Jun 20, 2025John Glenn
CHIEF FINANCIAL OFFICER
MOption exercise
Restricted Stock Unitsderivative
-5,796$0.00$05,796Jun 23, 2025
Jun 20, 2024John Glenn
CHIEF FINANCIAL OFFICER
MOption exercise
Restricted Stock Unitsderivative
-5,796$0.00$011,592Apr 7, 2025
Jun 20, 2024John Glenn
CHIEF FINANCIAL OFFICER
MOption exercise
Common Stock
+5,796--10,179Apr 4, 2025
Dec 7, 2024James B Hawkins
director
MOption exercise
Common Stock
+1,196--33,545Apr 4, 2025
Jun 20, 2024John Glenn
CHIEF FINANCIAL OFFICER
FTax withholding
Common Stock
-1,412$42.53$60k8,767Apr 4, 2025
Jun 20, 2024John Glenn
CHIEF FINANCIAL OFFICER
MOption exercise
Restricted Stock Unitsderivative
+5,796$0.00$011,592Apr 4, 2025
Dec 11, 2024Jeff Chiprin
Chief Commercial Officer
AGrant or award
Restricted Stock Unitsderivative
+2,990$0.00$02,990Dec 13, 2024
Dec 11, 2024John Glenn
CHIEF FINANCIAL OFFICER
AGrant or award
Restricted Stock Unitsderivative
+5,436$0.00$040,508Dec 13, 2024
Dec 11, 2024Monty K Allen
director
AGrant or award
Restricted Stock Unitsderivative
+1,811$0.00$03,008Dec 13, 2024
Dec 11, 2024James B Hawkins
director
AGrant or award
Restricted Stock Unitsderivative
+1,811$0.00$03,008Dec 13, 2024
Dec 11, 2024Hilda Frederique Scharen-Guivel
director
AGrant or award
Restricted Stock Unitsderivative
+1,811$0.00$03,008Dec 13, 2024
Dec 11, 2024Anthony Vuoto
director
AGrant or award
Restricted Stock Unitsderivative
+1,811$0.00$03,008Dec 13, 2024
Dec 11, 2024Jeff Chiprin
Chief Commercial Officer
AGrant or award
Performance-based Restricted Stock Unitsderivative
+2,989$0.00$02,989Dec 13, 2024
Dec 11, 2024John Glenn
CHIEF FINANCIAL OFFICER
AGrant or award
Performance-based Restricted Stock Unitsderivative
+5,435$0.00$023,119Dec 13, 2024
Dec 7, 2024Monty K Allen
director
MOption exercise
Common Stock
+1,751--19,804Dec 10, 2024
Dec 7, 2024Anthony Vuoto
director
MOption exercise
Common Stock
+1,751--15,985Dec 10, 2024
Dec 7, 2024James B Hawkins
director
MOption exercise
Common Stock
+1,751--41,099Dec 10, 2024
Dec 7, 2024Hilda Frederique Scharen-Guivel
director
MOption exercise
Common Stock
+1,196--4,729Dec 10, 2024
Dec 7, 2024Hilda Frederique Scharen-Guivel
director
MOption exercise
Restricted Stock Unitsderivative
-1,196$0.00$01,197Dec 10, 2024
Dec 7, 2024Monty K Allen
director
MOption exercise
Common Stock
+1,196--21,000Dec 10, 2024
Dec 7, 2024Anthony Vuoto
director
MOption exercise
Common Stock
+1,196--17,181Dec 10, 2024
Dec 7, 2024James B Hawkins
director
MOption exercise
Common Stock
+1,196--42,295Dec 10, 2024
Dec 7, 2024Anthony Vuoto
director
MOption exercise
Restricted Stock Unitsderivative
-1,751$0.00$00Dec 10, 2024
Dec 7, 2024Monty K Allen
director
MOption exercise
Restricted Stock Unitsderivative
-1,751$0.00$00Dec 10, 2024
Dec 7, 2024James B Hawkins
director
MOption exercise
Restricted Stock Unitsderivative
-1,751$0.00$00Dec 10, 2024
Dec 7, 2024Anthony Vuoto
director
MOption exercise
Restricted Stock Unitsderivative
-1,196$0.00$01,197Dec 10, 2024
Dec 7, 2024Monty K Allen
director
MOption exercise
Restricted Stock Unitsderivative
-1,196$0.00$01,197Dec 10, 2024
Dec 7, 2024James B Hawkins
director
MOption exercise
Restricted Stock Unitsderivative
-1,196$0.00$01,197Dec 10, 2024
Dec 2, 2024John Glenn
CHIEF FINANCIAL OFFICER
SOpen-market sale
Common Stock
-2,500$54.18$135k4,383Dec 2, 2024
Nov 6, 2024Anthony Vuoto
director
SOpen-market sale
Common Stock
-2,690$55.99$151k14,234Nov 6, 2024
Oct 14, 2024Hilda Frederique Scharen-Guivel
director
MOption exercise
Common Stock
+1,767--3,533Oct 15, 2024
Oct 14, 2024Hilda Frederique Scharen-Guivel
director
MOption exercise
Restricted Stock Unitsderivative
-1,767$0.00$01,767Oct 15, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

IRMD insider trading: IRADIMED CORP | InsiderTell